Evidence map›Paper›PMID 42802365›Full record

ArticleMicrobiologyOpen2026

A Novel Nanoantibiotic Formulation With Magnetic and Targeting Potential: Ampicillin-Conjugated L-glu-Fe

Mehmet Demirel, Ozlem Baris, Mesut Taskin, Seyda Albayrak, Ferhunde Aysin, Azada Aliyeva, Buket Bakan

Abstract read
In one paragraph

Article in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mehmet DemirelDepartment of Molecular Biology and Genetics, Faculty of Science, Atatürk University, Erzurum, Turkey.
Ozlem BarisDepartment of Biology, Faculty of Science, Atatürk University, Erzurum, Turkey.ORCID https://orcid.org/0000-0002-2679-5599
Mesut TaskinDepartment of Molecular Biology and Genetics, Faculty of Science, Atatürk University, Erzurum, Turkey.ORCID https://orcid.org/0000-0002-9350-9628
Seyda AlbayrakDepartment of Molecular Biology and Genetics, Faculty of Science, Atatürk University, Erzurum, Turkey.
Ferhunde AysinDepartment of Biology, Faculty of Science, Atatürk University, Erzurum, Turkey.ORCID https://orcid.org/0000-0003-1971-8031
Azada AliyevaDepartment of Molecular Biology and Genetics, Faculty of Science, Atatürk University, Erzurum, Turkey.
Buket BakanDepartment of Molecular Biology and Genetics, Faculty of Science, Atatürk University, Erzurum, Turkey.ORCID https://orcid.org/0000-0002-4400-6776

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Magnetic nanoparticles (NPs) are maintained in the body for a significantly longer duration than small molecule antibiotics, potentially facilitating prolonged therapeutic effects. In this study, a novel nanoantibiotic formulation (l-glu-Fe

Indexed as

AmpicillinAnti-Bacterial AgentsGlutamic AcidMagnetic Iron Oxide NanoparticlesMagnetite NanoparticlesBacillus cereusMicrobial Sensitivity TestsReactive Oxygen SpeciesSpectroscopy, Fourier Transform InfraredStaphylococcus aureusAmpicillinAnti-Bacterial AgentsGlutamic AcidMagnetite NanoparticlesReactive Oxygen Speciesampicillinchemistrydrug deliverymagnetic nanoparticlesnanoantibiotics

Identifiers

PMID42802365
PMCPMC13617144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.